To determin e the effect of Nef on viral replication, PBMCs were infected with HIV-1 NL4-3 mutants containing the ind icated nef genes or a disrupted nef codon (second bar). Cells were stimulated with PHA three days before infection (SI) or infected immediately after isolation and stimulated three days later (IS). All infections were performed with virus stocks containing 10 ng o f p24 capsid antigen and virus production was monitored by RT assay. Results were derived from triplicate infections (each) of three PBMC donors and represent cumulative virus pro ductio n over 2 1 days of viral replication. Presented are means ±SEM relative to cultures infected with NL4-3 expressing the NA7 Nef (100%). To measure virion infectivity, P4-CCR5 cells were infected with HIV-1 constructs expressing the indicated nef alleles. Infections were p erformed in triplicate with virus stocks containing 5 ng of p24 antigen. Shown are mean values o f six measurements (±SEM) relative to wild type NA7 Nef (100%). Downmodulation of CD4 and MHC-I in Jurkat T cells transfected with pCG constructs exp ressing the various nef alleles was d etermined as described (Kirchhoff et al., 2004) . For the quantification of Nef-mediated do wnregulation, the mean channel numbers of red fluorescence were determined for untransfected and transfected (eGFP+) cells. Mean values of three transfections ±SEM are shown. The "*" indicates that these mutatio ns affected the p oly-p urine tract; thus, this HIV-1 construct is not competent for replication. The yellow bars highlight mutants defective in NF-kB activation but not in most other functions. 
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Supplemental Experimental Procedures
Cell culture and transfections. 293T and HeLa cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FCS plus 2 mM glutamine, streptomycin (120 mg/ml), penicillin (120 mg/ml) and transfected by the calcium phosphate method as described previously (Münch et al., 2007) or using lipofectamine according to the manufacturer's instructions, respectively. SupD1 cells were maintained in RPMI medium supplemented with 10% FCS plus 2 mM glutamine, streptomycin (120 mg/ml), penicillin (120 mg/ml) and Hygromycin B (200 µg/ml). PBMCs from healthy human donors were isolated using lymphocyte separation medium (Biocoll separating solution; Biochrom), stimulated for 3 days with phytohemagglutinin (PHA) (1 µg/ml), and cultured in RPMI-1640 medium with 10% fetal calf serum (FCS) plus 2 mM glutamine, streptomycin (120 mg/ml), penicillin (120 mg/ml) and 10 ng/ml interleukin 2 (IL-2) prior to infection. Human lymphoid aggregate cultures (HLACs) were obtained from mechanically dispersed tonsillar explants from patients with informed consent. Cells were passed through 40 µm cells strainers and washed with PBS. 5 x 10 6 cells/ml were cultured in RPMI supplemented with 10% FCS, 2 mM glutamine, streptomycin (120 mg/ml), penicillin (120 mg/ml), gentamycin (50 mg/ml), timentin (310 µg/ml), 1% sodium pyruvate, 1% fungizone and 1% non-essential amino acids. EMSA. Nuclear extracts were prepared from nuclei using a rapid protocol described by Osborn et al. (Osborn et al., 1999) . The DNA sequence of the coding strand of the HIV-1 NL4-3 isolate LTR NF-κB oligonucleotide (nt -110 to -78) was as follows: 5'-TACAAGGGACTTTCCGCTGGGG-ACTTTCCAGGG-3'. For analysis of NF-κB binding, the double-stranded NF-κB oligonucleotide was 5'
NF-κB activation. To determine the effect of Nef or
end-labeled with [-32 P]ATP (>5000 Ci/mmol; Perkin Elmer) and T4 polynucleotide kinase, purified after isolation from polyacrylamide gel, and used as probe. Nuclear extract (10 µg of protein) was first incubated at room temperature for 10 min in the absence of probe DNA in a 16 µl reaction mixture containing 2 µg of DNase-free bovine serum albumin, 2 µg of poly(dI-dC) (Sigma) as non-specific competitor DNA, 1 mM dithiothreitol, 20 mM Tris-HCI pH 7.5, 60 mM KCI, 1 mM MgCl 2 , 0.1 mM EDTA and 10% (v/v) glycerol. Probe (30000 c.p.m.) was then added to the mixture and incubated for 20 min at room temperature. The reaction mixture was loaded directly onto a 6% non-denaturing polyacrylamide gel which had been pre-electrophoresed for 1 h at 150 V. Samples were electrophoresed at room temperature at 150 V for 2-3 h in 1x TGE buffer (25mM Tris-acetate, pH 8.3, 190 mM glycine, 1 mM EDTA). Gels were dried and autoradiographic exposures were carried out with Kodak BioMax MR films for 16-24 h at -70°C with intensifying screens. As loading controls, the same nuclear extracts were tested for binding of Oct1 to an Oct1 consensus probe (5'-TGTCGAATGCAAATCACTAGAA-3').
Quantitative analyses of EMSA and Western blot were performed using the ImageJ software.
Nef expression vectors and proviral constructs. HIV-1 NA7 nef mutants were generated by oligo-directed site-specific mutagenesis and subcloned into CMV-based pCG expression vectors as described previously (Greenberg et al., 1997) . These bi-cistronic expression vectors contain nef followed by eGFP under the translational control of the EMCV internal ribosome entry site (IRES) element and thus coexpress the various HIV-1 Nef proteins together with the GFP reporter molecule from a single bi-cistronic mRNA. Vectors containing these mutant nef alleles were kindly provided by Jacek
Skowronski. Proviral HIV-1 NL4-3 based constructs containing these mutant nef alleles were constructed by replacing the parental NL4-3 nef gene by the mutant nef alleles via splice overlap extension PCR essentially as described previously . All mutations and PCR-derived sequences were verified by DNA sequencing.
Flow cytometric analysis of Nef-mediated receptor modulation. Jurkat T cells were transfected by using the DMRIE-C reagent (Gibco-BRL) for subsequent detection of CD4 and MHC-I. Expression of CD4 and MHC-I on Jurkat T cells was measured as described previously (Brenner et al., 2006) . For quantification of Nef-mediated downmodulation the mean channel numbers of red fluorescence obtained for cells transfected with the control construct expressing GFP only was divided by the corresponding numbers obtained for cells coexpressing Nef and GFP to calculate the values for n-fold downmodulation.
The activity of the parental NA7 Nef was set to 100%.
Infectivity assays. Virus infectivity was determined using P4-CCR5. Briefly, the cells were sown out in 96-well dishes in a volume of 100 μl and infected after overnight incubation with virus stocks containing 10 ng of p24 antigen produced by transiently transfected 293T cells. Two days post-infection viral infectivity was detected using a galactosidase screen kit from Tropix as recommended by the manufacturer. β-galactosidase activities were quantified as relative light units per second using an Orion Microplate Luminometer. To calculate percentages, values obtained for the HIV-1 NL4-3 construct containing the wt NA7 Nef were set to 100%.
Viral replication in PBMC cultures.
To determine the replication of HIV-1 constructs differing in their nef genes, either PBMC were stimulated with phytohemagglutinin (PHA, 2 μg/ml) and 10 ng/ml IL-2 for 3 days prior to infection (SI) or unstimulated PBMCs were sown out immediately after isolation and infected with virus stocks containing 10 ng of p24 antigen (IS). In the latter case, the cells were stimulated with PHA (2 μg/ml) and 10 ng/ml IL-2 for two days at three days post-infection. After stimulation, PBMCs were cultivated in RPMI medium containing 10 ng/ml IL-2. Supernatants were harvested at regular intervals, and fresh medium was added. The extent of viral replication was determined by reverse transcriptase (RT) assay over three weeks of culture as described previously (Münch et al., 2007) . All experiments were performed in cells derived from three PBMC donors. Quantitative RT-PCR. Total RNA was isolated and purified from transduced PBMCs using the RNeasy Plus Mini Kit (QIAGEN) and 400 ng of RNA were reversely transcribed using the ThermoScript RT-PCR system with oligo dT primers (Invitrogen). Generated cDNA was subjected to quantitative real time PCR using exon-spanning TaqMan primer/probe sets for human IFNB1, ICAM-1, HLA-B, ICAM-1, IFI44L (LifeTechnologies) in duplex reactions with RNaseP as control. Ct data was processed relative to the RNaseP control.
